Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Investor Presentation
investor PPT24-01-2024
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Investor Presentation
investor PPTLaurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press ReleaseLaurus Labs Ltd - 540222 - Financial Results For Q3 FY 2024
Financial results for Q3 FY 2024Laurus Labs Ltd - 540222 - Grant Of Stock Options To The Eligible Employees
Grant of stock options to eligible employeesLaurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q3 FY 24 Earnings Conference CallLaurus Labs Ltd - 540222 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2023Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5)Laurus Labs Ltd - 540222 - Closure of Trading Window
Trading window is closed from January 01, 2024 till 48 hours after the declaration of financial results for the quarter and nine months ended December 31, 2023Buy or sell: Vaishali Parekh recommends three stocks to buy today December 19
Buy or sell stocks: Vaishali Parekh has recommended three stocks to buy today Laurus Labs, Amara Raja Energy and CEATLaurus Labs shares dip as USFDA issues 5 observations to Visakhapatnam arm
The inspection was conducted from December 4 to 12, 2023.